Skip to content

The Validity and Reliability Study of the Chelsea Critical Care Physical Assesment Tool

The Validity and Reliability of the Turkish Version of the Chelsea Critical Care Physical Assesment Tool

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04811638
Enrollment
50
Registered
2021-03-23
Start date
2021-01-11
Completion date
2021-01-14
Last updated
2023-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU Acquired Weakness, ICU Patients

Keywords

Physical Function, Critical İll, ICU Acquired Weakness

Brief summary

This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity.

Detailed description

Survival has increased in the ICU due to technological developments , but physical disability after discharge has become an important problem. İntensive Care Unit Acquired Weakness(ICU-AW) is seen in most of the patients admitted in this unit. The biggest reasons for ICU-AW are; sepsis, multiple organ failure and prolonged mechanical ventilation. The use of measurement tools to evaluate disabilities during stay and after discharge in intensive care unit, is a subject that has been researched all over the world.. These measurement tools provide; monitoring and evaluation during the ICU admission and assessment efficacy of treatment in the unit. The Chelsea Critical Care Physical Assessment Tool(CPAX) has been shown to valid, reliable and to exhibited strong clinimetric properties. CPAx is a numerical measurement tool, rated according to the 6-point Guttman Scale, from complete dependence to independence and consist of ten physical function parameters. This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity. The protocol includes a pre-test of the Turkish version on 10 patients, a final revision, and a validation on a sample of 40 İCU patients.

Interventions

OTHERValidation of the Chelsea Critical Care Physical Assesment Tools

The validation of the CPAX tools will focus on the validity of constructs, internal consistency reliability and test-retest reliability. PFIT used for criterion validity.

Sponsors

Medical Park Hospital Istanbul
CollaboratorOTHER
Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Older than 18 years * Critical adult patients * Patients who were hospitalized for more than 48 hours in an ICU

Exclusion criteria

* Unstable fracture * Limb deformities and dysfunction * Myasthenia gravis * Neuromuscular dysfunction * Patients who diagnosed COVİD-19

Design outcomes

Primary

MeasureTime frameDescription
Chelsea Critical Care Physical Assesment Toolsthree daysThe Chelsea critical care physical assessment (CPAx) is a measurement tool used to assess physical function in the ICU. The Chelsea critical care physical assessment (CPAx) tool is an outcome measure designed to assess 10 domains of physical ability: respiratory function, cough, bed mobility, supine to sitting on the edge of the bed, dynamic sitting, sit to stand, standing balance, transferring from bed to chair, stepping and grip strength. The validation of the CPAX tools will focus on the validity of constructs, internal consistency reliability and test-retest reliability.

Secondary

MeasureTime frameDescription
Physical Function in Intensive Care Testthree daysThe PFIT is a test that measures function status of patients with a variety of conditions in the ICU. It includes 5 items: amount of assistance for sit-to-stand transfers, strength for shoulder flexion, strength for knee extension, marching in place, and an upper extremity endurance task of arm elevation to 90 degrees of shoulder flexion. PFIT used for criterion validity.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026